Product Information

MIDODRINE HCL 5 MG TABLET is a generic product labeled by Xiromed LLC, priced at $0.1070 per EA under NDC 70700015801. Its NADAC has been published 305 times since Jan 13, 2021.

FDA first approved this application on Oct 1, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

MIDODRINE HCL 5 MG TABLET

midodrine hydrochloride
$0.1070per EA

Strength

5 mg/1

Manufacturer

Xiromed LLC

NDC

70700015801

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

MIDODRINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA207849

FDA Approved

10/1/2020

TE Code

AB

On Market Since

10/15/2020

Pharmacological Classes

Adrenergic alpha-Agonists
alpha-Adrenergic Agonist

Price Statistics

The NADAC for MIDODRINE HCL 5 MG TABLET has been published 305 times since Jan 13, 2021, and over the history we have for it it has declined 70.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1070 per EA
All-time high$0.3736 (Apr 14, 2021)
All-time low$0.1070 (Oct 21, 2026)
52-week high$0.1138
52-week low$0.1070
Median price$0.1757
Average price$0.1998
Largest weekly change+38.5% (Aug 21, 2024)
Weeks tracked305
Tracking sinceJan 13, 2021

Price History

1W

0.0%

1M

-3.9%

3M

-4.5%

6M

-3.9%

1Y

-5.4%

3Y

-33.7%

5Y

-69.8%

All

-70.0%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of MIDODRINE HCL 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for MIDODRINE HCL 5 MG TABLET, manufactured by Xiromed LLC, is $0.1070 per EA (NDC 70700015801), effective Nov 11, 2026.

How has the price of MIDODRINE HCL 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for MIDODRINE HCL 5 MG TABLET has declined 70.0%. It has been tracked across 305 weekly CMS publications since Jan 13, 2021.

What are the highest and lowest recorded NADAC prices for MIDODRINE HCL 5 MG TABLET?

Since Jan 13, 2021, the NADAC for MIDODRINE HCL 5 MG TABLET has ranged from a low of $0.1070 (Oct 21, 2026) to a high of $0.3736 (Apr 14, 2021), with a median of $0.1757 per EA.

Are there cheaper alternatives to MIDODRINE HCL 5 MG TABLET?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MIDODRINE HCL 5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures MIDODRINE HCL 5 MG TABLET?

MIDODRINE HCL 5 MG TABLET (NDC 70700015801) is labeled by Xiromed LLC, and CMS classifies it as a generic product.